Richardson, D. L., Moore, K. N., Hasegawa, K., Jelinic, P., Mailley, C., Re, S., Ma, W., Mitov, T., Ray-Coquard, I. L. (2026). REJOICE-Ovarian01: Phase 3 part of a phase 2/3 study evaluating raludotatug deruxtecan (R-DXd) versus treatment of physician’s choice in patients with platinum-resistant ovarian cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps5637